Centers | ||
MIPT Life Science Center | Edinburgh Drug Discovery | Therapeutic Accelerator Program (TAP) |
MIPT Life Sciences Center (LSC) is the MIPT department specializing in life sciences. The LSC carries out fundamental and applied research in the fields of pharmaceutics, development of new medical technologies, innovative diagnostic and treatment... |
Based within the world-leading University of Edinburgh Medical School, Edinburgh Drug Discovery has a track record in successfully translating drug discovery projects from target identification through to clinical evaluation. Key areas of... |
Test |
Partnerships |
Events |
Jobs |
Takeda Partners with Florida Hospital & Sanford-Burnham in Obesity AreaTakeda Pharmaceuticals has entered into a collaboration with Florida Hospital and Sanford-Burnham Medical Institute to discover and develop new therapeutic approaches to treat obesity. The two collaboration agreement will involve Takeda providing... View all Argenta and ANTABIO Announce Drug Discovery CollaborationArgenta, a Galapagos NV (Euronext: GLPG) company that provides drug discovery services from target validation to proof of concept, announced today that it has achieved a milestone with its collaboration partner Antabio in an anti-bacterial drug... View all UCB Partners with Oxford UniversityUCB has entered into a research and development partnership with Oxford University in Neurology and Immunology areas. UCB will provide 3.6 million pounds to Oxford scientists over a period of three year to conduct research. View all |
No EVENTS for listing |
No Job Posts |


